Triple
T6251195
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regeneron Pharmaceuticals |
E140048
|
entity |
| Predicate | knownFor |
P22
|
FINISHED |
| Object |
VelocImmune technology
VelocImmune technology is Regeneron’s proprietary platform that uses genetically engineered mice to rapidly produce fully human monoclonal antibodies for therapeutic development.
|
E579613
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c008b4858c819095b0199114a9a87b |
elicitation | completed |
| NER | batch_69c0633fb2ac8190b71b8e35fa923300 |
ner | completed |
| NED1 | batch_69c244240b448190be3645177194ced6 |
ned_source_triple | completed |
| NED2 | batch_69c275d913cc8190be3770f12c271226 |
ned_description | completed |
| NEDg | batch_69c2756cf5c88190aed2c5e0916082e7 |
nedg | completed |
Created at: March 22, 2026, 4:24 p.m.